MRK logo

Merck & Co (MRK)

Profile

Full Name

Merck & Co., Inc.

Ticker Symbol

MRK

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 13, 1978

Indexes

S&P 500,Dow Jones

Website

http://www.merck.com

Employees

73000

Key Details

Price

$76.84(+0.58%)

Market cap

$192.95B(Mega cap)

Last Dividend

$0.81

TTM Dividend yield

4.11%

Annual revenue

$64.17B(+6.74% YoY)

Annual EPS

$6.74(+4714.29% YoY)

PE ratio

11.18

Next earnings date

Jul 29, 2025

Next ex-dividend date

Jun 16, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $76.84
    MRK price is $76.84

    30-Day Relative Volume

    0.73
    MRK 30-day relative volume is 0.73

    Price Performance

    Price Today change

    +0.58%
    MRK price is up +0.58% today

    Price YTD change

    -22.76%
    MRK price is down -22.76% since January 1st

    Price 1-year change

    -38.3%
    MRK price is down -38.3% year-on-year

    Price 3-year change

    -17.45%
    MRK price is down -17.45% over the past 3 years

    Price Range

    Price All-time high

    $134.63
    MRK price is currently -42.93% below its historical high of $134.63

    Price 3-year low

    $73.31
    MRK price is currently +4.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $192.95B
    MRK market capitalization is $192.95 billion

    Market cap 3-year change

    -18.03%
    MRK market capitalization is down -18.03% over the past 3 years

    Market cap All-time high

    $337.37B
    MRK market capitalization is currently -42.81% below its historical high of $337.37 billion

    Market cap sector rank

    99.26%
    MRK market capitalization is higher than 99.26% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.86%
    MRK shares outstanding is down -0.86% year-on-year

    Shares Outstanding 3-Year Change

    -0.7%
    MRK shares outstanding is down -0.7% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.30
    MRK beta is 0.30

    200-day SMA

    $97.40
    MRK price is currently -21.11% below its 200-day simple moving average

    50-day SMA

    $81.27
    MRK price is currently -5.45% below its 50-day simple moving average

    RSI

    44.16
    MRK 14-day relative strength index is 44.16

    Volume

    0.73
    MRK 30-day relative volume is 0.73

    ATR

    $1.89
    MRK average true range is $1.89

    10-day Historical Volatility

    18.40%
    MRK 10-day historical volatility is 18.40%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.81
    MRK last dividend was $0.81 per share, with an ex-dividend date of March 17, 2025

    Next Dividend

    $0.81
    MRK has announced a dividend of $0.81 per share, with an ex-dividend date set for June 16, 2025

    Dividend per share

    Dividend per share

    $3.12
    MRK annual dividend per share is $3.12

    Dividend per share Sector Rank

    84.88%
    MRK annual dividend per share is higher than 84.88% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +5.41%
    MRK annual dividend per share is up +5.41% year-on-year

    Dividend per share 3-Year Change

    +18.18%
    MRK annual dividend per share is up +18.18% over the past 3 years

    Dividend yield

    Dividend yield

    4.06%
    MRK annual dividend yield is 4.06%

    Dividend yield Sector Rank

    78.82%
    MRK annual dividend yield is higher than 78.82% of companies in Healthcare sector

    Other

    Payout ratio

    45.80%
    MRK annual payout ratio is 45.80%

    Dividends paid

    $7.84B
    MRK annual dividends paid is $7.84 billion

    Free cash flow

    $18.10B
    MRK annual free cash flow is $18.10 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $64.17B
    MRK annual revenue is $64.17 billion

    Revenue Analysts estimate

    $65.04B
    MRK annual revenue is currently -1.34% lower than the consensus analysts' forecast

    Revenue 1-year change

    +6.74%
    MRK annual revenue is up +6.74% year-on-year

    Revenue Sector rank

    98.65%
    MRK annual revenue is higher than 98.65% of companies in Healthcare sector

    EPS

    EPS

    $6.74
    MRK annual earnings per share is $6.74

    EPS Analysts estimate

    $8.91
    MRK annual earnings per share is currently -24.37% lower than the consensus analysts' forecast

    EPS 1-year change

    +4714.29%
    MRK annual earnings per share is up +4714.29% year-on-year

    EPS Sector rank

    96.88%
    MRK annual earnings per share is higher than 96.88% of companies in Healthcare sector

    Profit

    Gross profit

    $48.98B
    MRK annual gross profit is $48.98 billion

    Gross margin

    76.32%
    MRK annual gross profit margin is 76.32%

    Operating profit

    $20.22B
    MRK annual operating income is $20.22 billion

    Operating margin

    31.51%
    MRK annual operating profit margin is 31.51%

    Net income

    $17.12B
    MRK annual net profit is $17.12 billion

    Net margin

    26.68%
    MRK annual net profit margin is 26.68%

    Expenses

    Total expenses

    $43.95B
    MRK annual total expenses is $43.95 billion

    Operating expenses

    $28.75B
    MRK annual total operating expenses is $28.75 billion

    Cost of goods sold

    $15.19B
    MRK annual cost of goods sold is $15.19 billion

    Selling, general & administrative expenses

    $10.82B
    MRK annual SGA is $10.82 billion

    Depreciation and amortization

    $4.50B
    MRK annual depreciation & amortization is $4.50 billion

    Interest expense

    $1.27B
    MRK annual interest expense is $1.27 billion

    Income tax

    $2.80B
    MRK annual income tax is $2.80 billion

    EBIT & EBITDA

    EBIT

    $20.22B
    MRK annual earnings before interest & taxes is $20.22 billion

    EBITDA

    $20.22B
    MRK annual EBITDA is $20.22 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $117.11B
    MRK annual total assets is $117.11 billion

    Non current assets

    $78.32B
    MRK annual long term assets is $78.32 billion

    Current assets

    $38.78B
    MRK annual total current assets is $38.78 billion

    Cash and cash equivalents

    $13.24B
    MRK annual cash & cash equivalents is $13.24 billion

    Accounts receivable

    $10.28B
    MRK annual accounts receivable is $10.28 billion

    Inventory

    $6.11B
    MRK annual inventory is $6.11 billion

    Liabilities

    Total liabilities

    $70.73B
    MRK annual total liabilities is $70.73 billion

    Long term liabilities

    $42.31B
    MRK annual total long term liabilities is $42.31 billion

    Current liabilities

    $28.42B
    MRK annual total current liabilities is $28.42 billion

    Accounts payable

    $4.08B
    MRK annual accounts payable is $4.08 billion

    Debt

    Total debt

    $37.11B
    MRK annual total debt is $37.11 billion

    Total debt 1-year change

    +5.87%
    MRK annual total debt is up +5.87% year-on-year

    Long term debt

    $34.46B
    MRK annual long term debt is $34.46 billion

    Short term debt

    $2.65B
    MRK annual short term debt is $2.65 billion

    Equity & Capital

    Shareholders equity

    $46.31B
    MRK annual stockholders equity is $46.31 billion

    Book value

    $46.31B
    MRK annual book value is $46.31 billion

    Retained earnings

    $63.07B
    MRK annual retained earnings is $63.07 billion

    Working capital

    $10.36B
    MRK annual working capital is $10.36 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $21.47B
    MRK annual cash flow from operations is $21.47 billion

    Cash from operations 1-year change

    +65.06%
    MRK annual cash flow from operations is up +65.06% year-on-year

    Cash from investing

    -$7.73B
    MRK annual cash flow from investing activities is -$7.73 billion

    Cash from investing 1-year change

    +45.08%
    MRK annual cash flow from investing activities is up +45.08% year-on-year

    Cash from financing

    -$7.03B
    MRK annual cash flow from financing activities is -$7.03 billion

    Cash from financing 1-year change

    -46.2%
    MRK annual cash flow from financing activities is down -46.2% year-on-year

    CAPEX

    CAPEX

    $3.37B
    MRK annual capital expenditures is $3.37 billion

    CAPEX 1-year change

    -12.71%
    MRK annual capital expenditures is down -12.71% year-on-year

    Free Cash Flow

    Free cash flow

    $18.10B
    MRK annual free cash flow is $18.10 billion

    Free cash flow 1-year change

    +97.92%
    MRK annual free cash flow is up +97.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    76.32%
    MRK annual gross profit margin is 76.32%

    Operating margin

    31.51%
    MRK annual operating profit margin is 31.51%

    Net margin

    26.68%
    MRK annual net profit margin is 26.68%

    ROA & ROE

    ROA

    15.30%
    MRK annual return on assets is 15.30%

    ROE

    40.75%
    MRK annual return on equity is 40.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    11.18
    MRK price to earnings ratio is 11.18

    PE ratio Sector rank

    18.31%
    MRK price to earnings ratio is higher than 18.31% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.99
    MRK price to book ratio is 3.99

    PB ratio Sector rank

    76.77%
    MRK price to book ratio is higher than 76.77% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.02
    MRK price to sales ratio is 3.02

    PS ratio Sector rank

    51.66%
    MRK price to sales ratio is higher than 51.66% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $219.16B
    MRK enterprise value is $219.16 billion

    Enterprise value Sector rank

    99.34%
    MRK enterprise value is higher than 99.34% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.88
    MRK EV/EBITDA is 8.88

    EV/EBITDA Sector rank

    81.57%
    MRK EV/EBITDA is higher than 81.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.36
    MRK annual current ratio is 1.36

    Quick ratio

    1.15
    MRK annual quick ratio is 1.15

    Leverage

    Debt to equity

    0.80
    MRK annual debt to equity ratio is 0.80

    Interest coverage ratio

    15.91
    MRK annual interest coverage ratio is 15.91

    Risk & Stability

    Piotroski F-Score

    7
    MRK piotroski f-score is 7

    Altman Z-Score

    3.61
    MRK altman z-score is 3.61

    Analyst ratings

    Recent major analysts updates

    May 14, 25 Citigroup
    Neutral
    Apr 22, 25 Cantor Fitzgerald
    Neutral
    Apr 17, 25 Guggenheim
    Buy
    Feb 18, 25 Deutsche Bank
    Hold
    Feb 12, 25 Guggenheim
    Buy
    Feb 5, 25 Morgan Stanley
    Equal-Weight
    Feb 5, 25 Citigroup
    Buy
    Feb 5, 25 BMO Capital
    Market Perform
    Feb 5, 25 B of A Securities
    Buy
    Jan 28, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with MRK included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    Dow Jones companies
    S&P 500 companies
    Stocks below analysts price target
    Highest Market Cap Stocks
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Merck & Co?
    • Does Merck & Co pay dividends?
    • What sector is Merck & Co in?
    • What industry is Merck & Co in?
    • What country is Merck & Co based in?
    • When did Merck & Co go public?
    • Is Merck & Co in the S&P 500?
    • Is Merck & Co in the NASDAQ 100?
    • Is Merck & Co in the Dow Jones?
    • When was Merck & Co's last earnings report?
    • When does Merck & Co report earnings?
    • Should I buy Merck & Co stock now?

    What is the ticker symbol for Merck & Co?

    The ticker symbol for Merck & Co is NYSE:MRK

    Does Merck & Co pay dividends?

    Yes, Merck & Co pays dividends. The last payment was $0.81, with an ex-dividend date on March 17, 2025

    What sector is Merck & Co in?

    Merck & Co is in the Healthcare sector

    What industry is Merck & Co in?

    Merck & Co is in the Drug Manufacturers - General industry

    What country is Merck & Co based in?

    Merck & Co is headquartered in United States

    When did Merck & Co go public?

    Merck & Co's initial public offering (IPO) was on January 13, 1978

    Is Merck & Co in the S&P 500?

    Yes, Merck & Co is included in the S&P 500 index

    Is Merck & Co in the NASDAQ 100?

    No, Merck & Co is not included in the NASDAQ 100 index

    Is Merck & Co in the Dow Jones?

    Yes, Merck & Co is included in the Dow Jones index

    When was Merck & Co's last earnings report?

    Merck & Co's most recent earnings report was on Apr 24, 2025

    When does Merck & Co report earnings?

    The next expected earnings date for Merck & Co is Jul 29, 2025

    Should I buy Merck & Co stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page